These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 26905369

  • 1. Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread.
    Shibata T, Uchida H, Shiroyama T, Okubo Y, Suzuki T, Ikeda H, Yamaguchi M, Miyagawa Y, Fukuhara T, Cohen JB, Glorioso JC, Watabe T, Hamada H, Tahara H.
    Gene Ther; 2016 Jun; 23(6):479-88. PubMed ID: 26905369
    [Abstract] [Full Text] [Related]

  • 2. Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus.
    Okubo Y, Uchida H, Wakata A, Suzuki T, Shibata T, Ikeda H, Yamaguchi M, Cohen JB, Glorioso JC, Tagaya M, Hamada H, Tahara H.
    J Virol; 2016 Dec 15; 90(24):11096-11105. PubMed ID: 27707922
    [Abstract] [Full Text] [Related]

  • 3. Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs.
    Ikeda H, Uchida H, Okubo Y, Shibata T, Sasaki Y, Suzuki T, Hamada-Uematsu M, Hamasaki R, Okuda K, Yamaguchi M, Kojima M, Tanaka M, Hamada H, Tahara H.
    J Virol; 2021 Apr 12; 95(9):. PubMed ID: 33627393
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A double mutation in glycoprotein gB compensates for ineffective gD-dependent initiation of herpes simplex virus type 1 infection.
    Uchida H, Chan J, Goins WF, Grandi P, Kumagai I, Cohen JB, Glorioso JC.
    J Virol; 2010 Dec 12; 84(23):12200-9. PubMed ID: 20861246
    [Abstract] [Full Text] [Related]

  • 6. B Virus (Macacine Herpesvirus 1) Divergence: Variations in Glycoprotein D from Clinical and Laboratory Isolates Diversify Virus Entry Strategies.
    Patrusheva I, Perelygina L, Torshin I, LeCher J, Hilliard J.
    J Virol; 2016 Oct 15; 90(20):9420-32. PubMed ID: 27512063
    [Abstract] [Full Text] [Related]

  • 7. Simultaneous Insertion of Two Ligands in gD for Cultivation of Oncolytic Herpes Simplex Viruses in Noncancer Cells and Retargeting to Cancer Receptors.
    Leoni V, Petrovic B, Gianni T, Gatta V, Campadelli-Fiume G.
    J Virol; 2018 Mar 15; 92(6):. PubMed ID: 29263255
    [Abstract] [Full Text] [Related]

  • 8. Nectin-1 expression by squamous cell carcinoma is a predictor of herpes oncolytic sensitivity.
    Yu Z, Adusumilli PS, Eisenberg DP, Darr E, Ghossein RA, Li S, Liu S, Singh B, Shah JP, Fong Y, Wong RJ.
    Mol Ther; 2007 Jan 15; 15(1):103-13. PubMed ID: 17164781
    [Abstract] [Full Text] [Related]

  • 9. Insertion of a ligand to HER2 in gB retargets HSV tropism and obviates the need for activation of the other entry glycoproteins.
    Petrovic B, Gianni T, Gatta V, Campadelli-Fiume G.
    PLoS Pathog; 2017 Apr 15; 13(4):e1006352. PubMed ID: 28423057
    [Abstract] [Full Text] [Related]

  • 10. Nectin-2-mediated entry of a syncytial strain of herpes simplex virus via pH-independent fusion with the plasma membrane of Chinese hamster ovary cells.
    Delboy MG, Patterson JL, Hollander AM, Nicola AV.
    Virol J; 2006 Dec 27; 3():105. PubMed ID: 17192179
    [Abstract] [Full Text] [Related]

  • 11. Glycoprotein D homologs in herpes simplex virus type 1, pseudorabies virus, and bovine herpes virus type 1 bind directly to human HveC(nectin-1) with different affinities.
    Connolly SA, Whitbeck JJ, Rux AH, Krummenacher C, van Drunen Littel-van den Hurk S, Cohen GH, Eisenberg RJ.
    Virology; 2001 Feb 01; 280(1):7-18. PubMed ID: 11162814
    [Abstract] [Full Text] [Related]

  • 12. A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells.
    Leoni V, Gatta V, Casiraghi C, Nicosia A, Petrovic B, Campadelli-Fiume G.
    J Virol; 2017 May 15; 91(10):. PubMed ID: 28250120
    [Abstract] [Full Text] [Related]

  • 13. Mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism.
    Manoj S, Jogger CR, Myscofski D, Yoon M, Spear PG.
    Proc Natl Acad Sci U S A; 2004 Aug 24; 101(34):12414-21. PubMed ID: 15273289
    [Abstract] [Full Text] [Related]

  • 14. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.
    Roller DG, Dollery SJ, Doyle JL, Nicola AV.
    Virology; 2008 Dec 20; 382(2):207-16. PubMed ID: 18950828
    [Abstract] [Full Text] [Related]

  • 15. Oncolytic Herpes Simplex Virus Vectors Fully Retargeted to Tumor- Associated Antigens.
    Uchida H, Hamada H, Nakano K, Kwon H, Tahara H, Cohen JB, Glorioso JC.
    Curr Cancer Drug Targets; 2018 Dec 20; 18(2):162-170. PubMed ID: 28176649
    [Abstract] [Full Text] [Related]

  • 16. Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus.
    Krummenacher C, Baribaud F, Ponce de Leon M, Baribaud I, Whitbeck JC, Xu R, Cohen GH, Eisenberg RJ.
    Virology; 2004 May 01; 322(2):286-99. PubMed ID: 15110526
    [Abstract] [Full Text] [Related]

  • 17. Mapping sites of herpes simplex virus type 1 glycoprotein D that permit insertions and impact gD and gB receptors usage.
    Fan Q, Kopp S, Connolly SA, Muller WJ, Longnecker R.
    Sci Rep; 2017 Mar 03; 7():43712. PubMed ID: 28255168
    [Abstract] [Full Text] [Related]

  • 18. Use of chimeric nectin-1(HveC)-related receptors to demonstrate that ability to bind alphaherpesvirus gD is not necessarily sufficient for viral entry.
    Geraghty RJ, Fridberg A, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG.
    Virology; 2001 Jul 05; 285(2):366-75. PubMed ID: 11437670
    [Abstract] [Full Text] [Related]

  • 19. Triple gene-deleted oncolytic herpes simplex virus vector double-armed with interleukin 18 and soluble B7-1 constructed by bacterial artificial chromosome-mediated system.
    Fukuhara H, Ino Y, Kuroda T, Martuza RL, Todo T.
    Cancer Res; 2005 Dec 01; 65(23):10663-8. PubMed ID: 16322208
    [Abstract] [Full Text] [Related]

  • 20. Nectin-1 is a marker of thyroid cancer sensitivity to herpes oncolytic therapy.
    Huang YY, Yu Z, Lin SF, Li S, Fong Y, Wong RJ.
    J Clin Endocrinol Metab; 2007 May 01; 92(5):1965-70. PubMed ID: 17327376
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.